The latest report by IMARC Group, titled “Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global metabolomics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.55% during 2023-2028.
Metabolomics is a field of scientific study that focuses on the comprehensive analysis of metabolites, which are small molecules involved in the chemical processes and metabolism within living organisms. It involves identifying, quantifying, and characterizing metabolites present in biological samples, such as blood, urine, tissues, or cells. It provides a holistic view of the metabolic profile of an organism, shedding light on the dynamic biochemical processes occurring in various biological systems. By measuring and analyzing the abundance and changes in metabolites, metabolomics aims to understand the metabolic pathways, interactions, and responses associated with physiological and pathological conditions. It comprises a combination of analytical chemistry, mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, and bioinformatics. These tools aid in identifying and quantifying a wide range of metabolites, including amino acids, lipids, carbohydrates, nucleotides, and various other small molecules. It is also used in environmental studies, helping to assess the impact of environmental factors on living organisms, monitor pollution, and study the metabolic responses of organisms to environmental stressors. It is also valuable in nutrition science, as it allows researchers to explore the effects of diet on metabolism, identify dietary biomarkers, and understand the relationship between nutrition and health outcomes. Currently, metabolomics finds extensive applications in biomedical research, pharmaceutical development, nutrition science, environmental studies, and personalized medicine across the globe.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/metabolomics-market/requestsample
Metabolomics Market Trends and Drivers:
The global metabolomics market is primarily driven by the increasing demand for personalized medicine and precision healthcare. Metabolomics plays a crucial role in understanding individual variations in metabolism, identifying biomarkers for disease diagnosis, and developing targeted therapies based on metabolic profiles. Moreover, numerous technological advancements, such as mass spectrometry and nuclear magnetic resonance spectroscopy, that improved the accuracy and sensitivity of metabolomics analysis are positively influencing the market growth. Apart from this, metabolomics enables researchers and healthcare professionals to identify metabolic signatures associated with specific diseases, facilitating early detection, disease monitoring, and personalized treatment approaches. In line with this, the rising prevalence of chronic diseases, such as cardiovascular disorders, cancer, and diabetes, has augmented the demand for metabolomics solutions. Additionally, the increasing research activities in fields like nutrigenomics and toxicology have catalyzed market growth. Besides this, several favorable government initiatives and funding for metabolomics research and collaborations are propelling the market growth. Governments and research organizations recognize the potential of metabolomics in advancing healthcare and are providing financial support for research projects, infrastructure development, and academic-industry partnerships. Furthermore, the rising applications of metabolomics in systems biology and personalized medicine owing to the integration of metabolomics with other omics technologies, such as genomics and proteomics, are contributing to the market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Metabolomics Instruments
- Metabolomics Bioinformatics Tools and Services
Breakup by Indication:
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- Others
Breakup by Application:
- Biomarker and Drug Discovery
- Toxicology
- Nutrigenomics
- Personalized Medicine
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Agilent Technologies Inc.
- Biocrates Life Sciences AG
- Bio-Rad Laboratories Inc.
- Bruker Corporation
- Danaher Corporation
- Human Metabolome Technologies Inc.
- Metabolon Inc.
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
